This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Jazz Pharmaceuticals Ireland Limited. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Jeffrey Silverman: Innovator in Recombinant L-Asparaginase
Introduction
Jeffrey Silverman is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of treatments for diseases that can be managed through asparagine depletion. With a total of 2 patents to his name, Silverman continues to push the boundaries of medical innovation.
Latest Patents
One of Silverman's latest patents is titled "Dosing and Administration of Recombinant L-Asparaginase." This invention provides compositions and methods for treating diseases that are treatable by asparagine depletion in human subjects. The method involves administering recombinant L-asparaginase to patients, showcasing Silverman's commitment to advancing therapeutic options in medicine.
Career Highlights
Jeffrey Silverman is currently associated with Jazz Pharmaceuticals Ireland Limited, where he applies his expertise in biotechnology to develop innovative solutions. His work at Jazz Pharmaceuticals highlights his dedication to improving patient outcomes through scientific advancements.
Collaborations
Silverman has collaborated with talented individuals such as Mi Rim Choi and Tong Lin. These partnerships reflect the collaborative spirit of innovation in the biotechnology sector.
Conclusion
Jeffrey Silverman is a prominent figure in the field of biotechnology, with a focus on recombinant L-asparaginase. His contributions through patents and collaborations demonstrate his commitment to advancing medical treatments.